NO20054898L - Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse - Google Patents

Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse

Info

Publication number
NO20054898L
NO20054898L NO20054898A NO20054898A NO20054898L NO 20054898 L NO20054898 L NO 20054898L NO 20054898 A NO20054898 A NO 20054898A NO 20054898 A NO20054898 A NO 20054898A NO 20054898 L NO20054898 L NO 20054898L
Authority
NO
Norway
Prior art keywords
compounds
preparation
pharmaceutical compositions
compositions containing
action
Prior art date
Application number
NO20054898A
Other languages
English (en)
Inventor
Carlo Parini
Carlo Farina
Stefania Gagliardi
Marisa Martinelli
Carla Ghelardini
Original Assignee
Nikem Res Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikem Res Srl filed Critical Nikem Res Srl
Publication of NO20054898L publication Critical patent/NO20054898L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)

Abstract

Den foreliggende oppfinnelsen tilveiebringer nye bisyklisk arylimidazoloner med noofropisk virkning (det vil si som beskytter og stimulerer hjemefimksjoner), smertestillende virkning og antihypersmertestillende virkning; fomten at det også tilveiebringes en fremgangsmåte for deres fremstiUing, fomten farmasøytiske sammensetninger som omfatter nevnte forbindelser, og hvor sammensetningene kan brukes for behandling av forskjelhge typer kognitiv svikt og for forskjellige typer av smerte.
NO20054898A 2003-03-24 2005-10-24 Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse NO20054898L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000573A ITMI20030573A1 (it) 2003-03-24 2003-03-24 Composti ad azione nootropica, loro preparazione,
PCT/EP2004/050339 WO2004085438A2 (en) 2003-03-24 2004-03-22 Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents

Publications (1)

Publication Number Publication Date
NO20054898L true NO20054898L (no) 2005-10-24

Family

ID=33042696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054898A NO20054898L (no) 2003-03-24 2005-10-24 Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse

Country Status (24)

Country Link
US (3) US7544705B2 (no)
EP (1) EP1608655B8 (no)
JP (1) JP4920408B2 (no)
CN (1) CN100522963C (no)
AT (1) ATE401327T1 (no)
AU (1) AU2004224087B2 (no)
BR (1) BRPI0408601A (no)
CA (1) CA2520008C (no)
CY (1) CY1108401T1 (no)
DE (1) DE602004015089D1 (no)
DK (1) DK1608655T3 (no)
EA (1) EA009558B1 (no)
ES (1) ES2309534T3 (no)
HK (1) HK1083837A1 (no)
HR (1) HRP20050833A2 (no)
IT (1) ITMI20030573A1 (no)
NO (1) NO20054898L (no)
NZ (1) NZ543154A (no)
PL (2) PL378939A1 (no)
PT (1) PT1608655E (no)
RS (1) RS20050725A (no)
SI (1) SI1608655T1 (no)
WO (1) WO2004085438A2 (no)
ZA (1) ZA200508578B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
ITMI20070770A1 (it) * 2007-04-16 2008-10-17 Brane Discovery S R L Impiego di dimiracetam nel trattamento del dolore cronico
AU2012201853B2 (en) * 2007-04-16 2013-06-27 Neurotune Ag Use of dimiracetam in the treatment of chronic pain
JP5917148B2 (ja) 2008-10-16 2016-05-11 ザ ジョーンズ ホプキンズ ユニバーシティＴｈｅ Ｊｏｈｎｓ Ｈｏｐｋｉｎｓ Ｕｎｉｖｅｒｓｉｔｙ 認知機能を改善するための方法および組成物
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
EP2533645B1 (en) * 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
PL2598504T3 (pl) * 2010-07-26 2014-10-31 Neurotune Ag Sposób otrzymywania dimiracetamu
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
US10925834B2 (en) 2015-05-22 2021-02-23 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
JOP20190251A1 (ar) 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
CN113164767A (zh) 2018-12-04 2021-07-23 美蒂斯制药公司 包含非外消旋比例的(r)-2-(2-氧代-1-吡咯烷基)丁酰胺和(s)-2-(2-氧代-1-吡咯烷基)丁酰胺的协同组合物
CN113195494A (zh) 2018-12-04 2021-07-30 美蒂斯制药公司 包含非外消旋比例的R-2-(取代的磺酰基)-六氢-吡咯并[1,2-a]吡嗪-6(2H)-酮和S-2-(取代的磺酰基)-六氢-吡咯并[1,2-a]吡嗪-6(2H)-酮的协同组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582838A (en) * 1984-08-24 1986-04-15 Warner-Lambert Company Derivatives of dihydro-1H-pyrrolo[1,2-c]imidazol-3,5-dione as cognition activators
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
US5200406A (en) * 1988-02-08 1993-04-06 I.S.F. Societa Per Azioni Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines
JP3400466B2 (ja) * 1991-10-28 2003-04-28 日本水産株式会社 高純度エイコサペンタエン酸またはそのエステルの製造方法
GB9123641D0 (en) * 1991-11-07 1992-01-02 Isf Spa Process
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Also Published As

Publication number Publication date
HRP20050833A2 (en) 2006-02-28
DE602004015089D1 (de) 2008-08-28
PL1608655T3 (pl) 2009-03-31
DK1608655T3 (da) 2008-11-03
JP4920408B2 (ja) 2012-04-18
US7544705B2 (en) 2009-06-09
EA200501501A1 (ru) 2006-04-28
RS20050725A (en) 2007-11-15
EP1608655A2 (en) 2005-12-28
ZA200508578B (en) 2007-04-25
WO2004085438A3 (en) 2004-11-25
NZ543154A (en) 2008-03-28
US20090163565A1 (en) 2009-06-25
CA2520008C (en) 2011-08-23
CY1108401T1 (el) 2014-02-12
CN100522963C (zh) 2009-08-05
BRPI0408601A (pt) 2006-03-07
EA009558B1 (ru) 2008-02-28
ES2309534T3 (es) 2008-12-16
US7732473B2 (en) 2010-06-08
WO2004085438A2 (en) 2004-10-07
AU2004224087B2 (en) 2010-04-01
CA2520008A1 (en) 2004-10-07
SI1608655T1 (sl) 2008-12-31
JP2006523198A (ja) 2006-10-12
US20070027137A1 (en) 2007-02-01
EP1608655B1 (en) 2008-07-16
CN1756757A (zh) 2006-04-05
HK1083837A1 (en) 2006-07-14
ATE401327T1 (de) 2008-08-15
ITMI20030573A1 (it) 2004-09-25
PT1608655E (pt) 2008-10-07
EP1608655B8 (en) 2008-10-15
US20100173945A1 (en) 2010-07-08
PL378939A1 (pl) 2006-06-12
AU2004224087A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
NO20054898L (no) Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse
MXPA05005223A (es) Diaminotriazoles utiles como inhibidores de proteinas cinasas.
MY139730A (en) Cyclic protein tyrosine kinase inhibitors
MXPA05010711A (es) Compuestos y composiciones novedosos como inhibidores de proteina-quinasa.
TW200504015A (en) Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
ATE419253T1 (de) Inhibitoren von thienopyridin- und furopyridinkinase
AU3113902A (en) Thiazolyl inhibitors of tec family tyrosine kinases
TW200514776A (en) Aminotriazole compounds useful as inhibitors of protein kinases
NO20071915L (no) Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer
BR0312785A (pt) Tratamento de desordens relacionadas a tnf(alfa)
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
MXPA05010496A (es) Moduladores alostericos positivos del receptor de acetilcolina nicotinico.
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE464303T1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
MXPA06011327A (es) Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
EA200400073A1 (ru) Пирролопиримидины как ингибиторы протеинкиназы
TR200500221T2 (tr) Farmasötik Maddeler Olarak Bisiklik Amino Asitler
NO20076447L (no) Bicykliske derivater som modulatorer av ionekanaler
MXPA05007792A (es) Prodrogas de propofol derivadas de aminoacido, composiciones y usos de las mismas.
DE602004012578D1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
WO2006037032A3 (en) Prodrugs of protein tyrosine kinase inhibitors
UA87494C2 (en) Azaindoles useful as inhibitors of jak and other protein kinases
ATE414526T1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
BR112021022380A2 (pt) Inibidores de jak

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application